James B Breitmeyer insider trades

Open-market stock purchases and sales by James B Breitmeyer, Director at Vaxart, Inc, from SEC Form 4 filings since Jan 5, 2010.

Recent trades

DateStockTradeValue
Apr 23, 2026VXRT Vaxart, IncBought (not open market)—
Apr 23, 2026VXRT Vaxart, IncBought (not open market)—

Companies traded

  • VXRT Vaxart, Inc: other filings, last Apr 23, 2026
  • ONCT Oncternal Therapeutics, Inc: 4 buys, last Feb 14, 2024
  • OTIC Otonomy, Inc: other filings, last Jun 21, 2022
  • ZGNX Zogenix, Inc: 2 sales, last Mar 7, 2022
  • CADX Cadence Pharmaceuticals Inc: 14 sales, last Mar 14, 2012

Get free alerts when James B Breitmeyer files a new trade →